foxo4-dri senolytic 2024 study Senolytics: charting a new course or enhancing existing anti-tumor therapies? FOXO4-DRI alleviates age-related testosterone secretion
Description
Unapproved drugs aren't FDA-reviewed
Regular, moderate-intensity physical exercise has a positive effect on intestinal epithelial status and intestinal barrier integrity
Current Pharmaceutical Design, 24(18), 1972-1989
Human clinical evidence for TB-500 (a synthetic form of thymosin beta-4) is limited because most peer-reviewed studies involve the native peptide thymosin beta-4 in wound-healing settings rather than TB-500 specifically, but research does show its regenerative and anti-inflammatory effects in humans
That's why we tailor each patient's therapy plan to their specific needs
